Transparency Market Research (TMR) has published a new report titled, “Extracorporeal CO2 Removal Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. According to the report, the global extracorporeal CO2 removal market was valued at US$ 50.0 Mn in 2017 and is projected to expand at a CAGR of 6.0% from 2018 to 2026. Rise in demand for innovative technologies and adoption of ECCO2R devices is expected to boost the growth of the global extracorporeal CO2 removal market from 2018 to 2026. North America and Europe are anticipated to dominate the global market during the forecast period owing to early availability of novel medical technologies, developed health care infrastructure, and increased patient awareness.
Asia Pacific is expected to account for significant market share by 2026. This is attributed to large chronic obstructive pulmonary disease (COPD) and acute respiratory distress syndrome (ARDS) patient base in developing countries such as China and India. Rise in adoption of technologically advanced products manufactured by key manufacturers such as ALung Technologies and Xenios AG is likely to drive the global ECCO2R market.
Request A Sample-
Rise in Demand for Minimally Invasive Ventilation to Drive Market
ECCO2R technique is widely used to avoid invasive mechanical ventilation, especially in patients failing non-invasive ventilation. It also has a feasible therapeutic application to facilitate mechanical ventilation in ARDS patients. ECCO2R can be a promising adjuvant therapeutic strategy for the management of patients with severe exacerbations of COPD and to achieve protective or ultra-protective ventilation in patients with ARDS without life-threatening hypoxemia. Rise in demand for minimally invasive ventilation is anticipated to propel the extracorporeal CO2 removal market during the forecast period. Over invasive mechanical ventilation extracorporeal life support offers safer simpler respiratory applications with veno-venous support and biocompatible membranes.